Intelligent Medicine Acquisition Corp.

Intelligent Medicine Acquisition Corp. (Nasdaq: IQMD) is a blank check company formed to pursue a business combination in the healthcare and life sciences sector. The SPAC completed its initial public offering in 2021 and filed a Form 10-Q with the SEC on May 17, 2022, covering the quarterly period during which the company remained in its pre-combination search phase. IQMD's stated acquisition strategy focuses on intelligent medicine and health technology opportunities, positioning the vehicle within the broader medtech and healthcare innovation space. Sponsor details and deal timeline data are tracked in full on SpacDesk — sign up today for complete access to IQMD's filing history and real-time status updates.